company background image
CBD logo

Cannasouth NZSE:CBD Stock Report

Last Price

NZ$0.098

Market Cap

NZ$32.4m

7D

0%

1Y

n/a

Updated

19 Apr, 2024

Data

Company Financials

CBD Stock Overview

Cannasouth Limited, a medicinal cannabis company, engages in the manufacture of cannabis-based ingredients and oral solutions.

CBD fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Cannasouth Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cannasouth
Historical stock prices
Current Share PriceNZ$0.098
52 Week HighNZ$0.32
52 Week LowNZ$0.096
Beta0
1 Month Change-1.01%
3 Month Change-13.27%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-67.33%

Recent News & Updates

Does Cannasouth (NZSE:CBD) Have A Healthy Balance Sheet?

Mar 15
Does Cannasouth (NZSE:CBD) Have A Healthy Balance Sheet?

Recent updates

Does Cannasouth (NZSE:CBD) Have A Healthy Balance Sheet?

Mar 15
Does Cannasouth (NZSE:CBD) Have A Healthy Balance Sheet?

Shareholder Returns

CBDNZ PharmaceuticalsNZ Market
7D0%-3.8%-0.8%
1Yn/a32.1%-4.5%

Return vs Industry: Insufficient data to determine how CBD performed against the NZ Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how CBD performed against the NZ Market.

Price Volatility

Is CBD's price volatile compared to industry and market?
CBD volatility
CBD Average Weekly Movement10.9%
Pharmaceuticals Industry Average Movement10.8%
Market Average Movement4.2%
10% most volatile stocks in NZ Market7.5%
10% least volatile stocks in NZ Market2.4%

Stable Share Price: CBD's share price has been volatile over the past 3 months.

Volatility Over Time: CBD's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of NZ stocks.

About the Company

FoundedEmployeesCEOWebsite
n/an/aMark Lucaswww.cannasouth.co.nz

Cannasouth Limited, a medicinal cannabis company, engages in the manufacture of cannabis-based ingredients and oral solutions. It produces medicinal cannabis products and cannabinoid-based medicines to treat and support the health of patients with certain conditions. It also exports its products.

Cannasouth Limited Fundamentals Summary

How do Cannasouth's earnings and revenue compare to its market cap?
CBD fundamental statistics
Market capNZ$32.39m
Earnings (TTM)-NZ$8.81m
Revenue (TTM)NZ$955.55k

33.9x

P/S Ratio

-3.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CBD income statement (TTM)
RevenueNZ$955.55k
Cost of RevenueNZ$2.18m
Gross Profit-NZ$1.22m
Other ExpensesNZ$7.59m
Earnings-NZ$8.81m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.027
Gross Margin-127.65%
Net Profit Margin-921.78%
Debt/Equity Ratio5.9%

How did CBD perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.